Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy.

Saved in:
Bibliographic Details
Title: Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy.
Authors: Tang Y; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA., Liu W; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA., Kadu S; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA., Johnson O; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA., Hasanali ZS; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Kelly A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA., Shestov A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA., Pajarillo R; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Greenblatt E; IsoPlexis, Bradford, CT., Holmes M; IsoPlexis, Bradford, CT., Wang LP; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Shih N; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., O'Connor RS; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Ruella M; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Garfall AL; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Allman D; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Vogl DT; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Cohen A; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., June CH; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Sheppard NC; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Source: Blood [Blood] 2024 Jan 11; Vol. 143 (2), pp. 139-151.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood.2022018658